Stock data
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP) reported revenue of US$3.51M and net income of -US$581.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$3.51M | — | -US$664.57M | -US$581.60M | — |
| 2024 | US$37.31M | — | -US$466.57M | -US$366.25M | — |
| 2023 | US$371.21M | — | -US$222.54M | -US$153.61M | — |
| 2022 | US$1.20M | — | -US$673.16M | -US$650.17M | — |
| 2021 | US$914.96M | — | US$373.53M | US$377.66M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$10.18M | -US$91.15M | — |
| 2026-03-31 | US$1.46M | -US$122.93M | — |
| 2025-12-31 | US$0.86M | -US$130.61M | — |
| 2025-09-30 | US$0.89M | -US$106.44M | — |
| 2025-06-30 | US$0.89M | -US$208.55M | — |
| 2025-03-31 | US$0.86M | -US$136.00M | — |
| 2024-12-31 | US$35.69M | -US$37.31M | — |
| 2024-09-30 | US$0.60M | -US$85.94M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.